Chlordiazepoxide interactions with scopolamine and dizocilpine: Novel cooperative and antagonistic effects on spatial learning

Behavioral Neuroscience

Volumn 119, Issue 5, 2005, Pages 1331-1338

  Padlubnaya, Diana ^a   Galizio, Mark ^a   Pitts, Raymond C ^a   Keith, Julian R ^a  

^a UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

Author keywords

Benzodiazepine; Memory; NMDAR antagonist; Scopolamine; Spatial learning

Indexed keywords

BENZODIAZEPINE; CHLORDIAZEPOXIDE; DIZOCILPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESCAPE BEHAVIOR; LATENT PERIOD; LEARNING; MALE; MEMORY; NEUROTRANSMISSION; NONHUMAN; RAT; SPATIAL MEMORY; SWIMMING; TRAINING;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESCAPE REACTION; EXCITATORY AMINO ACID ANTAGONISTS; GABA MODULATORS; LEARNING; MALE; MAZE LEARNING; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SCOPOLAMINE; SPATIAL BEHAVIOR; SWIMMING;

EID: 27744605134     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.119.5.1331     Document Type: Article

References (37)

1. Abe, K., Takeyama, C., & Yoshimura, K. (1998). Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats. European Journal of Pharmacology, 547, 145-152.
2. Areosa, S. A., McShane, R., & Sherriff, F. (2004). Memantine for dementia. Cochrane Database of Systematic Reviews, 4, CD003154.
3. Armstrong, D. M., Sheffield, R., Mishizen-Eberz, A. J., Carter, T. L., Rissman, R. A., Mizukami, K., et al. (2003). Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease. Cellular and Molecular Neurobiology, 23, 491-505.
4. Arvidsson, A., Kokaia, Z., & Lindvall, O. (2001). N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. European Journal of Neuroscience, 14, 10-18.
5. Bernabeu, R., & Sharp, F. R. (2000). NMDA and AMPA/kainate glutamate receptors modulate dentate neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus. Journal of Cerebral Blood Flow and Metabolism, 20, 1669-1680.
6. Cain, D. P. (1998). Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning. Neuroscience and Biobehavioral Reviews, 22, 181-193.
7. Cain, D. P., Ighanian, K., & Boon, F. (2000). Individual and combined manipulation of muscarinic, NMDA, and benzodiazepine receptor activity in the water maze task: Implications for a rat model of Alzheimer dementia. Behavioural Brain Research, 111, 125-137.
8. Collingridge, G. L. (2003). The induction of N-methyl-D-aspartate receptor-dependent long-term potentiation. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, 358, 635-641.
9. Doraiswamy, P. M. (2002). Non-cholinergic strategies for treating and preventing Alzheimer's disease. CNS Drugs, 16, 811-824.
10. Duka, T., Ott, H., Rohloff, A., & Voet, B. (1996). The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory, and psychomotor skills. Psychopharmacology (Berlin), 123, 361-373.
11. Evans, M. S., & Viola-McCabe, K. E. (1996). Midazolam inhibits long-term potentiation through modulation of GABAA receptors. Neuropharmacology, 35, 347-357.
12. Galizio, M., Keith, J. R., Mansfield, W. J., & Pitts, R. C. (2003). Repeated spatial acquisition: Effects of NMDA antagonists and morphine. Experimental and Clinical Psychopharmacology, 11, 79-90.
13. Haefely, W. E., Martin, J. R., Richards, J. G., & Schoch, P. (1993). The multiplicity of actions of benzodiazepine receptor ligands. Canadian Journal of Psychiatry/Revue Canadienne De Psychiatrie, 38(Suppl. 4), S102-S108.
14. Keith, J. R., & Galizio, J. W. (1997). Acquisition in the Morris swim task is impaired by a benzodiazepine but not an NMDA antagonist: A new procedure for distinguishing acquisition and performance effects. Psychobiology, 25, 217-228.
15. Keith, J. R., Pitts, R. C., Pezzuti, T., & Galizio, M. (2003). Effects of positive GABA(A) modulators on a multiple-component, repeated-acquisition test of spatial learning. Behavioural Pharmacology, 14, 67-75.
16. Keith, J. R., & Rudy, J. W. (1990). Why NMDA-receptor-dependent long-term potentiation may not be a mechanism of learning and memory: Reappraisal of the NMDA-receptor blockade strategy. Psychobiology, 18, 251-257.
17. Khanna, J. M., Chau, A., & Shah, G. (1997). Effect of NMDA antagonists on rapid tolerance to benzodiazepines. Brain Research Bulletin, 42, 99-103.
18. Kopelman, M. D., & Corn, T. H. (1988). Cholinergic "blockade" as a model for cholinergic depletion: A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain, 111, 1079-1110.
19. Lagnaoui, R., Moore, N., Moride, Y., Miremont-Salame, G., & Begaud, B. (2003). Benzodiazepine utilization patterns in Alzheimer's disease patients. Pharmacoepidemiology and Drug Safety, 12, 511-515.
20. Lodge, D., & Johnson, K. M. (1990). Noncompetitive excitatory amino acid receptor antagonists. Trends in Pharmacological Sciences, 11, 81-86.
21. Mao, J., Sung, B., Ji, R. R., & Lim, G. (2002). Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. Journal of Neuroscience, 22, 7650-7661.
22. McEwen, B. S. (2002). Sex, stress, and the hippocampus: Allostasis, allostatic load, and the aging process. Neurobiology of Aging, 23, 921-939.
23. McNamara, R. K., dePape, G. E., & Skelton, R. W. (1993). Differential effects of benzodiazepine receptor agonists on hippocampal long-term potentiation and spatial learning in the Morris water maze. Brain Research, 626, 63-70.
24. McNaughton, N., & Morris, R. G. (1987). Chlordiazepoxide, an anxiolytic benzodiazepine, impairs place navigation in rats. Behavioural Brain Research, 24, 39-46.
25. Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods, 11, 47-60.
26. Morris, R. G. (1989). Synaptic plasticity and learning: Selective impairment of learning rats and blockade of long-term potentiation in vivo by the W-methyl-D-aspartate receptor antagonist AP5. Journal of Neuroscience, 9, 3040-3057.
27. Saucier, D., Hargreaves, E. L., Boon, F., Vanderwolf, C. H., & Cain, D. P. (1996). Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: Nonspatial pretraining eliminates spatial learning deficits. Behavioral Neuroscience, 110, 103-116.
28. Skolnick, P., Layer, R. T., Popik, P., Nowak, G., Paul, I. A., & Trullas, R. (1996). Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression. Pharmacopsychiatry, 29, 23-26.
29. Sonkusare, S. K., Kaul, C. L., & Ramarao, P. (2005). Dementia of Alzheimer's disease and other neurodegenerative disorders: Memantine, a new hope. Pharmacological Research, 51, 1-17.
30. Steppuhn, K. G., & Turski, L. (1993). Diazepam dependence prevented by glutamate antagonists. Proceedings of the National Academy of Sciences of the United States of America, 90, 6889-6893.
31. Sutherland, R. J., Whishaw, I. Q., & Regehr, J. C. (1982). Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat. Journal of Comparative Physiology. A, Sensory, Neural, and Behavioral Physiology (Berlin), 96, 563-573.
32. Tuominen, H. J., Tiihonen, J., & Wahlbeck, K. (2005). Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis. Schizophrenia Research, 72, 225-234.
33. Twyman, R. E., Rogers, C. J., & Macdonald, R. L. (1989). Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Annals of Neurology, 25, 213-220.
34. Van Sickle, B. J., Cox, A. S., Schak, K., Greenfield, L. J., Jr., & Tietz, E. I. (2002). Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression(1). Neuropharmacology, 43, 595-606.
35. Villarroya, M., Garcia, A. G., & Marco, J. L. (2004). New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease. Current Pharmaceutical Design, 10, 3177-3184.
36. Wiley, J. L., & Balster, R. L. (2004). Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats. Life Sciences, 75, 141-151.
37. Willetts, J., Balster, R. L., & Leander, J. D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences, 11, 423-428.